RMDN3 and amyotrophic lateral sclerosis: Amyotrophic lateral sclerosis (ALS)-linked protein TDP-43 disrupts MAMs by impairing the VAPB–PTPIP51 complex via activation of glycogen synthase kinase-3β (GSK3β) (Stoica et al., 2014).